Bulk ingredients

CPHI 2023

Spotlight on moisture sensitive excipients for Roquette at CPHI

18-Oct-2023 By Liza Laws

Provider of pharmaceutical and nutraceutical ingredients, Roquette, is excited to unveil its extensive range of excipients for moisture protection at CPHI Barcelona next week.

Operio makes manufacturing acquisition with European expansion aim

11-Apr-2023 By Ben Hargreaves

Operio has acquired a group of companies that provide both manufacturing equipment and services in the solid dose space.

Zebra adds new environmental sensors for pharma supply chain

23-Mar-2023 By Ben Hargreaves

The company launches its new ZS300 sensor, ZB200 bridge and Android sensor discovery app, which will be made available for use with the supply chains of the pharma and food industries.

Bluepharma invests €30M in industrial unit for oncology drugs

20-Mar-2023 By Liza Laws

Portuguese pharma company, Bluepharma, has opened an industrial unit specializing in producing oral solid, high potent drugs in the oncology area.

CatSci Ltd and AGC Pharma Chemicals announce their strategic partnership

16-Mar-2023 By Liza Laws

Medicine developer, CatSci Ltd announced yesterday (March 15) that it has formed a new partnership with AGC Pharma Chemicals, a small molecule Contract Development and Manufacturing Organisation (CDMO).

Piramal begins production at API facility in Michigan

20-Feb-2023 By Ben Hargreaves

The Indian company begins production of APIs and HPAPIs, after expanding capacity at its Riverview site.

HPAPI Summit hones in on pharmaceutical manufacturing risk

25-Apr-2022 By Jenni Spinner

The 2022 edition of the Highly Potent Active Pharmaceutical Ingredients Summit (June 28 to 30 in Boston) will take on a range of topics, including safety.

Resilience, collaboration can drive pharma innovation: IFF

03-Jan-2022 By Jenni Spinner

A representative from IFF Pharma Solutions talks about significant challenges in drug development and improvements the industry can implement to overcome them.

Continuus lands $69.3m US drug manufacturing contract

21-Jan-2021 By Jenni Spinner

The small-molecule pharmaceuticals manufacturer secured a DoD/HHS government contract to manufacture critical medicines for a range of conditions.

FDA puts spotlight on compounded drugs, opens educational center

07-Jan-2020 By Vassia Barba

In an aim to improve quality assurance and control of compounded medicine, the US FDA opens a Compounding Quality Center of Excellence.

Sartorius in $750m swoop for Danaher Life Science businesses

22-Oct-2019 By Ben Hargreaves

Sartorius is set to acquire three biopharma businesses from Danaher, once the latter company concludes its deal for GE Biopharma.

Cambrex doubles footprint at its crystallization facility

01-Aug-2019 By Vassia Barba

Cambrex to scale up its solid form screening and crystallization process development facility in Edinburgh to answer market demand for larger scale crystallization.

Gene therapy manufacturing partnership to support ‘booming’ market

03-Dec-2018 By Maggie Lynch

Axovant has signed a strategic partnership agreement with the CDMO Yposkesi to support its growing gene therapy pipeline.

Supply chain summed up: Innovations, partnerships, and deals in 2018

13-Nov-2018 By Maggie Lynch

Supply chain companies have been busy in 2018. Here, we're wrapping up some of the big moves made over the last year.

AAPS PharmSci 360 preview: ‘Small-conference feel and big-conference breadth’

30-Oct-2018 By Melissa Fassbender

AAPS PharmSci 360 is a new conference this year, created in response to a desire for “fresh science,” specifically with chemical and biomolecular components. So what can you expect?

Cambrex cements North Carolina presence with buildings purchase

01-Oct-2018 By Maggie Lynch

Cambrex, a small molecule and API manufacturer, announced it will expand to establish a ‘center of excellence’ for process and development of its API clinical supply.

State of the Industry

State of the Industry: Taking the pulse of the contract services market

11-Jun-2018 By Melissa Fassbender

Following on from the success of last year's survey, Outsourcing-Pharma is running another 'state of the industry' survey to gauge views about the current state of the pharmaceutical contract services industry.

AMRI awarded seven-year NIH contract

06-Jun-2018 By Melissa Fassbender

AMRI will support the development and manufacture of active pharmaceutical ingredients (API) and drug product for Phase I clinical studies under a seven-year contract with the NIH.

WuXi AppTec IPO tops $353m

09-May-2018 By Melissa Fassbender

The Chinese contract research and development company WuXi AppTec has raised more than $353m in its initial public offering of common stock on the Shanghai Stock Exchange.

Researchers commercializing new method to accelerate drug development

03-May-2018 By Melissa Fassbender

A new method for determining the crystal structures of organic salts – which make up 40% of all APIs – could “greatly speed up” the drug development process, say researchers.

DCAT WEEK

CMOs, CDMOs give company updates at DCAT Week: Acquisitions, expansions on all sides

29-Mar-2018 By Melissa Fassbender

At DCAT Week, contract manufacturing and development companies from across the globe shared updates and news – from multi-million dollar investments to new business structures and areas of focus.

The Good, The Bad and the Ugly of CMO partnerships: A biotech perspective

13-Mar-2018 By Flora Southey

Partnering with CMOs makes sense for emerging biotechs, says Ardelyx exec James Kanter, who relies on networking and clear communication guidelines to manage third-party relationships.

People on the move

Outsourcing-Pharma’s Hiring and Firing Roundup February ‘18

28-Feb-2018 By Melissa Fassbender

CordenPharma has revamped its executive leadership team, Recipharm has named the head of its new global development organization, and several new CEOs have been appointed.

Scientist.com implementing process to address global requirements ahead of GDPR

19-Feb-2018 By Melissa Fassbender

Scientist.com is working to implement an improved contractual landscape ahead of GDPR implementation in May, in order to ensure global compliance among sponsors and CROs.

Cambrex up on innovator API demand, aims for double-digit growth

12-Feb-2018 By Dan Stanton

Cambrex Corporation says a preference among reference drugmakers for Western made APIs has helped produce robust quarterly results.

News in brief

BioDuro teams up with API developer Porton

01-Feb-2018 By Melissa Fassbender

The San Diego-CA-based contract research, development, and manufacturing organization (CDMO), BioDuro, has announced a cooperation agreement with Porton Pharma Solutions.

Ipca establishes foothold in US market with CMO purchase

17-Jan-2018 By Melissa Fassbender

Ipca Laboratories, a fully-integrated Indian pharmaceutical company, has purchased an NC-based CMO in a $9.65m deal that will enable it to manufacture small volume APIs for the US market.

Reports revisited: What we learned this year

20-Dec-2017 By Melissa Fassbender

Outsourcing models examined, market shifts scrutinized, and trial tribulations analyzed – take a look back at some of the top reports published in 2017.

4 trends driving industry priorities in 2018

20-Dec-2017 By Melissa Fassbender

Commercial transformation could reach new heights in 2018, says inVentiv – as new expectations (and possibilities) reshape traditional models.

Guest article

3 global trends driving transformations in healthcare product development

12-Dec-2017 By Sudip S. Parikh, PhD, senior vice president & managing director, DIA Americas

The healthcare product development ecosystem is undergoing massive changes. Significant transformations are underway in how drugs and medical devices are researched, developed, manufactured, and approved.

AMRI continues to up capacity amid ‘evolution of pharma pipelines’

04-Dec-2017 By Melissa Fassbender

AMRI has more than doubled its bulk Active Pharmaceutical Ingredient (API) aseptic manufacturing capacity in response to an increasing need for sterile API and an evolving pharma pipeline, says CCO.

People on the Move

Outsourcing-Pharma’s Hiring and Firing Roundup November ‘17

30-Nov-2017 By Melissa Fassbender

This month’s roundup includes new CEOs at Bioclinica and Comprehend Systems, several hires at Parexel's consulting division, and new roles – and new offices – for two service providers.

People on the Move

Outsourcing-Pharma’s Hiring and Firing Roundup October ‘17

31-Oct-2017 By Melissa Fassbender

This month’s round up includes Adent’s new product management director who joins the company from Eli Lily and a new CEO at Clinipace, as the CRO’s co-founder steps down after 14 years.

Single-source outsourcing model saves pharma sponsors $45m, Tufts report

26-Oct-2017 By Melissa Fassbender

Sponsors using a single-source outsourcing partner could potentially save up to $45m through reduced time to market, according to a recent Tufts study.

Printed meds accelerate clinical testing sans toxic solvents

05-Oct-2017 By Melissa Fassbender

A new technique for printing medications without using solvents can accelerate drug screening and clinical testing, say researchers.

Aurobindo hit with US FDA Form 483 for cephalosporin plant

27-Sep-2017 By Gareth Macdonald

Aurobindo Pharma Limited has received a Form 483 detailing two problems identified by US FDA inspectors who visited its Unit VI facility in in Chitkul Village, Andhra Pradesh, India.

Divi's Labs gets US FDA Form 483 for Vizag API plant

27-Sep-2017 By Gareth Macdonald

The US FDA has found more problems at a Divi’s Laboratories Limited API facility that was banned from shipping to the US earlier this year.

Outsourcing-Pharma's State of the Global Pharmaceutical Contract Services Industry

Outsourcing plans, demand, and relationships: readers weigh in on the state of the industry

07-Sep-2017 By Melissa Fassbender

The global pharmaceutical contract services industry continues to face several challenges and changes, from ubiquitous consolidation among all industry players to uncertainty in a turbulent political climate.

ScinoPharm showcases water treatment tech at Baxdela API plant

17-Aug-2017 By Gareth Macdonald

ScinoPharm has emphasised its compliance with waste water treatment rules, weeks after being contracted to supply API for Melinta Therapeutics’ antibiotic Baxdela.

STA: merger with WuXi division follows single source contract provider trend

01-Aug-2017 By Melissa Fassbender

STA Pharmaceutical has merged with WuXi AppTec’s Pharmaceutical Development Services (PDS) to create a “more complete and integrated platform.”

Compounding quality concerns: Legislation could 'fundamentally undermine' patient protections

25-Jul-2017 By Melissa Fassbender

Citing safety concerns, drug industry stakeholders and public health organizations are urging lawmakers to uphold FDA oversight and enforcement of the 2013 Drug Quality and Security Act (DQSA).

Pharma finance

It's a seller's market as buyers narrow therapeutic focus, says inVentiv

07-Jul-2017 By Melissa Fassbender

Biopharmaceutical dealmakers are narrowing in on therapeutic areas as company’s look to lead specific markets or gain a technical advantage.

Cambrex continues to up capacity with more than $200m invested in 5 years

31-May-2017 By Melissa Fassbender

Cambrex Corporation has increased new capacity at its Sweden-based cGMP as the manufacturer focuses on market demand and customer need, says VP.

People on the move

Outsourcing-Pharma's Hiring and Firing Roundup May '17

31-May-2017 By Melissa Fassbender

This month’s roundup includes new executive leadership teams, hires on both sides of the Atlantic for CRO Smithers Viscient, a new VP and medical director at Clinipace, among others.

Pharma finance

Outsourcing-Pharma

Resources